Mazanti-Andersen offers strong expertise in major listings, IPOs and cross-border capital markets transactions, also advising on complex M&A, stock exchange transitions, convertible bonds and variable equity financings. Practice head Lars Lüthjohan brings extensive experience across IPOs, rights and directed issues, acquisitions and sophisticated equity financing structures, making the firm a trusted advisor for high-value capital markets work.
Legal 500 Editorial commentary

Accolades

Client satisfaction: Sector knowledge

Testimonials

Collated independently by Legal 500 research team.

  • ‘Depth and specialisation combined with partner engagement, commercial understanding & client-centred approach.’
  • ‘They are full spectrum as well as niche strength: Many firms either focus on general commercial legal work or a few specialities. Mazanti appears both broad (many practice areas) and deep.’

Key clients

  • Allarity Therapeutics A/S and Inc.Ascendis Pharma A/S
  • Evaxion A/S

Work highlights

Assisted Ascendis Pharma A/S with a public offering of 2,300,000 American Depositary Shares.
Practice head

Lars Lūthjohan